Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Titel:
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Auteur:
Solomon, Benjamin J Besse, Benjamin Bauer, Todd M Felip, Enriqueta Soo, Ross A Camidge, D Ross Chiari, Rita Bearz, Alessandra Lin, Chia-Chi Gadgeel, Shirish M Riely, Gregory J Tan, Eng Huat Seto, Takashi James, Leonard P Clancy, Jill S Abbattista, Antonello Martini, Jean-François Chen, Joseph Peltz, Gerson Thurm, Holger Ou, Sai-Hong Ignatius Shaw, Alice T